A carregar...

Metastatic breast cancer: Endocrine therapy landscape reshaped

Endocrine therapy (ET) of hormone receptor (HR)-positive and human epidermal growth factor receptor 2-(HER2)-negative metastatic breast cancer (MBC) historically focused on estrogen deprivation and antagonism. The identification of several intracellular pathways promoting resistance to antiestrogen...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Avicenna J Med
Main Authors: Salkeni, Mohamad Adham, Hall, Samantha June
Formato: Artigo
Idioma:Inglês
Publicado em: Medknow Publications & Media Pvt Ltd 2017
Assuntos:
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC5655644/
https://ncbi.nlm.nih.gov/pubmed/29119080
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4103/ajm.AJM_20_17
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!